|
Volumn 49, Issue SUPL. S1, 2002, Pages 57-61
|
Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIFUNGAL AGENT;
FLUCONAZOLE;
FLUCYTOSINE;
ADULT;
AIDS RELATED COMPLEX;
ANTIFUNGAL ACTIVITY;
ARTICLE;
ASIA;
ASPERGILLOSIS;
AUSTRALIA;
CANDIDIASIS;
CEREBROSPINAL FLUID;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRYPTOCOCCOSIS;
CRYPTOCOCCUS NEOFORMANS;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG RESPONSE;
FEBRILE NEUTROPENIA;
FEMALE;
FUNGAL MENINGITIS;
FUSARIUM;
HUMAN;
INCIDENCE;
KIDNEY FAILURE;
MALE;
MUCORMYCOSIS;
MYCOSIS;
NEPHROTOXICITY;
NEW ZEALAND;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT FAILURE;
VARIETAS;
|
EID: 0036176759
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/49.suppl_1.57 Document Type: Article |
Times cited : (49)
|
References (11)
|